Literature DB >> 18484167

Three-dimensional echocardiographic assessment of left ventricular function in takotsubo cardiomyopathy.

Mie Fujikawa1, Junji Iwasaka, Chihiro Oishi, Takanao Ueyama, Haengnam Park, Yoshihiro Yamamoto, Hajime Otani, Toshiji Iwasaka.   

Abstract

We evaluated left ventricular (LV) function by three-dimensional echocardiography (3DE) in a patient with takotsubo cardiomyopathy (TC). An 82-year-old man was admitted to our hospital with a suspicion of acute myocardial infarction but was diagnosed as TC by coronary angiography and left ventriculography (LVG). Three-dimensional echocardiography showed circular asynergy from the midventricle to the apex associated with hyperkinesis of the base and volumetric data very close to those obtained by LVG. Thus, 3DE is a useful tool in evaluating regional wall motion abnormalities and LV volume in patients with TC.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18484167     DOI： 10.1007/s00380-007-1033-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN： 0910-8327            Impact factor:   2.037


  5 in total

1.  A case of takotsubo cardiomyopathy associated with epileptic seizure: reversible left ventricular wall motion abnormality and ST-segment elevation.

Authors:  Satoru Sakuragi; Naoto Tokunaga; Keisuke Okawa; Mikio Kakishita; Tohru Ohe
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

2.  A serious clinical course of a very elderly patient with takotsubo cardiomyopathy.

Authors:  Kenya Sakai; Hiroyuki Ochiai; Norihiko Katayama; Kenji Nakamura; Keiko Arataki; Tamako Kido; Hiroshi Iwamoto; Satoe Nakamura; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2005-03       Impact factor: 2.037

3.  Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan.

Authors:  K Tsuchihashi; K Ueshima; T Uchida; N Oh-mura; K Kimura; M Owa; M Yoshiyama; S Miyazaki; K Haze; H Ogawa; T Honda; M Hase; R Kai; I Morii
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

4.  Accuracy and feasibility of online 3-dimensional echocardiography for measurement of left ventricular parameters.

Authors:  Carly Jenkins; Jonathan Chan; Lizelle Hanekom; Thomas H Marwick
Journal:  J Am Soc Echocardiogr       Date:  2006-09       Impact factor: 5.251

5.  What is the optimal clinical technique for measurement of left ventricular volume after myocardial infarction? A comparative study of 3-dimensional echocardiography, single photon emission computed tomography, and cardiac magnetic resonance imaging.

Authors:  Jonathan Chan; Carly Jenkins; Frederick Khafagi; Leanne Du; Thomas H Marwick
Journal:  J Am Soc Echocardiogr       Date:  2006-02       Impact factor: 5.251
  5 in total
  5 in total

1.  Tako-tsubo cardiomyopathy complicated by ventricular septal perforation and septal dissection.

Authors:  Giovanni Mariscalco; Paolo Cattaneo; Andrea Rossi; Massimo Baravelli; Gabriele Piffaretti; Antonio Scannapieco; Daniele Nassiacos; Andrea Sala
Journal:  Heart Vessels       Date:  2010-01-21       Impact factor: 2.037

2.  A new ECG criterion to identify takotsubo cardiomyopathy from anterior myocardial infarction: role of inferior leads.

Authors:  Man-Hong Jim; Annie On-On Chan; Ping-Tim Tsui; Suet-Ting Lau; Chung-Wah Siu; Wing-Hing Chow; Chu-Pak Lau
Journal:  Heart Vessels       Date:  2009-04-01       Impact factor: 2.037

3.  Insights into the pathogenesis of takotsubo syndrome, which with persuasive reasons should be regarded as an acute cardiac sympathetic disease entity.

Authors:  Shams Y-Hassan
Journal:  ISRN Cardiol       Date:  2012-10-15

4.  Stress-induced cardiomyopathy: the role of echocardiography.

Authors:  Jun-Won Lee; Jang-Young Kim
Journal:  J Cardiovasc Ultrasound       Date:  2011-03-31

Review 5.  Epidemiology, pathogenesis, and management of takotsubo syndrome.

Authors:  Shams Y-Hassan; Per Tornvall
Journal:  Clin Auton Res       Date:  2017-09-15       Impact factor: 4.435
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.